Poor interobserver agreement in the distinction of high-grade dysplasia and adenocarcinoma in pretreatment Barrett's esophagus biopsies.
about
The risk of lymph-node metastases in patients with high-grade dysplasia or intramucosal carcinoma in Barrett's esophagus: a systematic reviewQuantitative analysis of high-resolution microendoscopic images for diagnosis of esophageal squamous cell carcinoma.The Presence of Genetic Mutations at Key Loci Predicts Progression to Esophageal Adenocarcinoma in Barrett's EsophagusInter- and intraobserver reliability and validation of a new method for determination of eosinophil counts in patients with esophageal eosinophiliaBiomarkers in Barrett's Esophagus.Comparison of nuclear texture analysis and image cytometric DNA analysis for the assessment of dysplasia in Barrett's oesophagus.Novel probe-based confocal laser endomicroscopy criteria and interobserver agreement for the detection of dysplasia in Barrett's esophagus.Detection of dysplasia in Barrett's esophagus with in vivo depth-resolved nuclear morphology measurementsEndoscopic mucosal resection results in change of histologic diagnosis in Barrett's esophagus patients with visible and flat neoplasia: a multicenter cohort study.Interobserver Variation in the Diagnosis of Gastric Epithelial Dysplasia and Carcinoma between Two Pathologists in Japan and Korea.The prevalence of Barrett's-esophagus-associated dysplasia in Puerto Rico.American Gastroenterological Association technical review on the management of Barrett's esophagusEvaluation of Mutational Testing of Preneoplastic Barrett's Mucosa by Next-Generation Sequencing of Formalin-Fixed, Paraffin-Embedded Endoscopic Samples for Detection of Concurrent Dysplasia and Adenocarcinoma in Barrett's Esophagus.Tissue and serum mesothelin are potential markers of neoplastic progression in Barrett's associated esophageal adenocarcinomaRadiofrequency Ablation Is Associated With Decreased Neoplastic Progression in Patients With Barrett's Esophagus and Confirmed Low-Grade DysplasiaBarrett's Esophagus: Emerging Knowledge and Management StrategiesPredictors of progression in Barrett's esophagus: current knowledge and future directionsProbe confocal laser endomicroscopy in the therapeutic endoscopic management of Barrett's dysplasia.Quantitative analysis of high-resolution microendoscopic images for diagnosis of neoplasia in patients with Barrett's esophagus.Increasing diagnostic accuracy to grade dysplasia in Barrett's esophagus using an immunohistochemical panel for CDX2, p120ctn, c-Myc and Jagged1Interobserver agreement among cytopathologists in the evaluation of pancreatic endoscopic ultrasound-guided fine needle aspiration cytology specimensDNA methylation as an adjunct to histopathology to detect prevalent, inconspicuous dysplasia and early-stage neoplasia in Barrett's esophagusBarrett's esophagus: where do we stand?Oesophageal biopsies are insufficient to predict final histology after endoscopic resection in early Barrett's neoplasiaTreatment of Barrett's esophagus with high-grade dysplasia.Poorly differentiated component in gastric pinch biopsies predicts submucosal invasion.Natural progression of dysplasia in adult recurrent respiratory papillomatosis.Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process.Histopathology in barrett esophagus and barrett esophagus-related dysplasia.The changing role of the pathologist in the management of Barrett's oesophagus.Progression of Barrett oesophagus: role of endoscopic and histological predictors.Minimally invasive esophagectomy for dysplastic Barrett's esophagus.Current issues in Barrett's esophagus and Barrett's-related dysplasia.Australian clinical practice guidelines for the diagnosis and management of Barrett's esophagus and early esophageal adenocarcinoma.Overdiagnosis of high-grade dysplasia in Barrett's esophagus: a multicenter, international study.Barrett's esophagus: diagnosis and management.Development of Quality Indicators for Endoscopic Eradication Therapies in Barrett's Esophagus: The TREAT-BE (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus) Consortium.Low prevalence of invasive adenocarcinoma and occult cancer on esophageal resection for Barrett's esophagus with high-grade dysplasia: Evidence for conservative managementAssessment of the diagnostic performance and interobserver variability of endocytoscopy in Barrett's esophagus: a pilot ex-vivo study.[Barrett's esophagus. An update].
P2860
Q27027036-D8CC2E20-E796-4E41-A423-A21C88B08B11Q27318999-EAA7E3A5-5690-48E1-BCDA-E0CAAC48C76FQ30654762-E5A8090E-4134-4B4C-B31D-E24068898130Q33956853-81A41F0A-CB79-4ADA-B601-695433F23B7FQ34011000-DEFAD9FC-990B-4706-AE18-B6B12BAC1F80Q34024948-9DC488BE-5F63-4C8E-9637-2C979A6008BCQ34030244-76E42665-B4D6-4BA2-A0A5-99382C0AC8A2Q34432328-18D21DDF-2F7C-4BBC-9A5D-8D4115BB522CQ35022528-34D5F8E2-597E-4A5B-AC2D-87BE4F30CE70Q35480821-87AB7543-DA25-4413-B0BF-4E91A48E66A9Q35619274-79E5D11E-9735-448C-AE07-42DF3F711F0AQ35673305-D71EC76D-8247-418E-BE0C-92846710B89CQ35792782-08D0066E-5C1D-4E5C-A706-1292D000944FQ35815574-C94FBA92-C9B0-433A-8D48-E7399C1924C2Q35998193-1B8D752E-E26B-4B95-909C-FE0514E71ABEQ36014649-6B52A734-2371-45CF-8389-CFBB922BBA9FQ36127891-68B3B47A-F139-4D01-876E-C1D743A47221Q36362578-B8FC9604-C2F5-4A04-804F-BBA7EEC0E968Q36405467-FBDF121E-4A2C-4DAF-9AB4-6A393CBB2F13Q36635061-B3A0E32D-E5EE-4838-BB15-D1F61BEE7745Q37195171-F9C28786-FECB-4E5E-8173-95839A6C2D9EQ37207287-1B297355-84E0-4698-B1E0-7770DC465CE1Q37243629-E0256447-E63A-4618-B40E-4F8284CEB21BQ37296589-F95E1B90-63B0-439E-9B57-807E906E61C3Q37411171-13A143E5-DE73-4849-9E60-ECB5BC437D17Q37609393-AE827406-5BFF-4864-A260-AD33084592F0Q37865265-322125CF-97E5-479F-80D2-3791C8B3B0B5Q38005810-39484B47-C3E4-4E3C-9FDB-0959246C23ADQ38191222-AF345A55-55EB-42A7-990F-FF9EFCE3C71FQ38210245-709732BD-B65D-4598-8433-06F2FCA98136Q38214785-E871F9B4-9984-400C-950F-0E0C49997C77Q38242032-4409923B-386C-474A-B345-F3419C8FEF02Q38308045-1E3622DB-C22A-4802-964B-E1DAD3EAD6C4Q38328606-B32A2E1A-8F70-48F9-BC4F-2D1B90F71F0AQ38353516-60655F10-E768-4EF8-B993-8CD04F4D7A84Q39097596-DDDAE0D5-9CAC-4F93-8509-C44CF6BBAB9AQ39344023-3B564C5D-AF00-4C10-8972-E2EB0EA7BD4BQ42143802-5A0FDC2A-B137-4DBD-BEA7-088463FC378CQ42780178-240AE47B-1657-4476-8D31-9021F04165C2Q53095026-18D43A2F-2457-4C89-9821-4B34FD941C94
P2860
Poor interobserver agreement in the distinction of high-grade dysplasia and adenocarcinoma in pretreatment Barrett's esophagus biopsies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Poor interobserver agreement i ...... Barrett's esophagus biopsies.
@en
Poor interobserver agreement i ...... Barrett's esophagus biopsies.
@nl
type
label
Poor interobserver agreement i ...... Barrett's esophagus biopsies.
@en
Poor interobserver agreement i ...... Barrett's esophagus biopsies.
@nl
prefLabel
Poor interobserver agreement i ...... Barrett's esophagus biopsies.
@en
Poor interobserver agreement i ...... Barrett's esophagus biopsies.
@nl
P2093
P1476
Poor interobserver agreement i ...... Barrett's esophagus biopsies.
@en
P2093
Ana E Bennett
Elias Castilla
Erinn Downs-Kelly
Joel E Mendelin
John R Goldblum
Lisa A Rybicki
Lisa Yerian
Lynn Schoenfield
Marek Skacel
Mary P Bronner
P304
2333-40; quiz 2341
P356
10.1111/J.1572-0241.2008.02020.X
P407
P577
2008-07-30T00:00:00Z